C vs NRIX · P/E 16, rev $85.22B vs rev $54.5M
Citigroup Inc. (C) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
C currently screens at market cap $214.73B and trailing P/E 15.5. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the C and NRIX stock pages for the full models.
Not investment advice.